메뉴 건너뛰기




Volumn 74, Issue 2-3, 2000, Pages 135-140

Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: Characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors

Author keywords

Alzheimer's disease; CDD 0102; Memory function; Molecular modeling; Muscarinic receptor; Site directed mutagenesis; Xanomeline

Indexed keywords

5 (3 ETHYL 1,2,4 OXADIAZOL 5 YL) 1,4,5.6 TETRAHYDROPYRIMIDINE TRIFLUOROACETIC ACID; CDD 0102; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; TETRAHYDROPYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG; XANOMELINE;

EID: 0343294314     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00026-6     Document Type: Article
Times cited : (27)

References (25)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.